PodParley PodParley
AAD's Dialogues in Dermatology cover art

All Episodes

AAD's Dialogues in Dermatology — 265 episodes

#
Title
1

Treatment of Psoriasis in Children (Sponsored by Johnson and Johnson)

2

Bonus: Acne in Skin of Color (Sponsored by Ortho Dermatologics)

3

Bonus: Practice Management Series: 2026 Dermatology Coding Updates

4

Bonus: 2026 ABD Continuing Certification Program Changes - What Dermatologists Need to Know

5

Vulvar Neoplasms: Benign and Malignant

6

Practice Management Series: Payer and Regulatory Challenges in Dermatopathology

7

Bonus: Treatment Decision in Oral vs Injectable Systemic Therapies in Psoriasis (Sponsored by Johnson & Johnson)

8

Practice Management Series: What's New With HIT

9

Bonus: Managing Challenging Atopic Dermatitis Cases (Supported by Pfizer)

10

Bonus: DiD You Know? – Learn About Updated Guidelines for Patch Testing Patients on Immunomodulatory Medications

11

Practice Management Series: Documentation requirements that support whether reporting a malignant procedure code is appropriate or not

12

Bonus: DiD You Know? – Spare the Steroids: Explore the Effects of IL-5 Inhibitors for Drug-Induced Hypersensitivity Syndrome (DIHS)

13

Bonus: How Large Language Models (AI) Fail for Clinical Reasoning

14

Bonus: Current Approaches to the Treatment of Early Mycosis Fungoides (Sponsored by Kyowa Kirin)

15

Practice Management Series: Teledermatology Updates

16

Practice Management Series: Telehealth Coding for 2025 and Beyond

17

Bonus: Diagnosis, Management, and Updates on Chronic Spontaneous Urticaria (Supported by Novartis)

18

Bonus: Itch Related to Prurigo Nodularis (Supported by Galderma)

19

Practice Management Series: How to Succeed in 2025 with the MIPS Program

20

Bonus: Recap of 2025 Patient Safety and Quality Symposium

21

Bonus: DiD You Know? – A Critical Assessment: Dive into the Development of a New Personalized Risk Model for Cutaneous Squamous Cell Carcinomas

22

Bonus: Itch Related to Atopic Dermatitis (Supported by Galderma)

23

Bonus: AAD 2025 Election: President-Elect (Dr. Andrew H. Weinstein) and Vice President-Elect (Dr. Thomas E. Rohrer)

24

Bonus: AAD 2025 Election: President-Elect Interview (Dr. Andrew H. Weinstein)

25

Bonus: AAD 2025 Election: President-Elect Interview (Dr. Cyndi J. Yag-Howard)

26

Practice Management Series: Change Health Cyberattack

27

December JAAD Series: Approach to Mycosis Fungoides in children (ARMFUL study): consensus-based recommendations

28

Updates on JAK Inhibitors for Alopecia Areata (Supported by Pfizer)

29

Augmented Intelligence Series: The Pitfalls of AI - What to be Aware of and Cautious With

30

Augmented Intelligence Series: How I'm Using AI in Clinic

31

Bonus: New Approaches to Diagnosis of Early Mycosis Fungoides (Sponsored by Kyowa Kirin)

32

Practice Management Series: Coding Updates for 2025

33

November JAAD Series: Early Post-Operative Water Exposure Does Not Increase Complications in Cutaneous Surgeries: A Randomized, Investigator-Blinded, Controlled Trial

34

Bonus: DiD You Know? – Not So Straightforward: How Brazilian Hair Straightening Treatments Can Cause Severe Acute Kidney Injury in Patients

35

October JAAD Series: Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy & Part II: Lactation

36

Practice Management Series: Teledermatology

37

Bonus: Generalized Pustular Psoriasis - Expert Insights, Digital Fingerprints, and the Power of DataDerm

38

Bonus: Antifungal Resistant Dermatophytes

39

Bonus: Volunteer Abroad - Beginners

40

Bonus: Medicare Payment Crisis: How Did We Get Here?

41

September JAAD Series: Diagnosis and Management of Longitudinal Erythronychia: A Clinical Review by an Expert Panel

42

Practice Management Series: Reporting CMS E&M visit complexity HCPCS add-on code G2211 in a dermatology setting

43

August JAAD Series: Perioperative management of immunomodulatory agents in patients with psoriasis and psoriatic arthritis

44

Practice Management Series: Advocating for Appropriate Modifier 25 Payment

45

Practice Management Series: Know Before you Sign Payer Contracts: Red Flags and Tips

46

Practice Management Series: Getting Paid for Multiple Procedures on the Same DOS

47

July JAAD Series: Clinical characteristics and symptom progression of dermatomyositis subtypes: a retrospective analysis of a prospective database

48

Practice Management Series: Maximizing the use of social media to expand dermatologic care

49

June JAAD Series: Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation

50

Bonus: Human Trafficking in Dermatology

51

Practice Management Series: How to succeed in 2024 with the MIPS Program

52

Bonus: Management of Unresectable BCC (Sponsored by Regeneron Pharmaceuticals)

53

May JAAD Series: Generalized Pustular Psoriasis: A Consensus Statement from the National Psoriasis Foundation

54

Bonus: Recap of 2024 Patient Safety and Quality Symposium

55

Bonus: What’s New in the Management of High-Risk SCC (Sponsored by Regeneron Pharmaceuticals)

56

Practice Management Series: Physician Burnout and Wellness

57

Bonus: AAD 2024 Election: President-Elect (Dr. Murad Alam) and Vice President-Elect (Dr. Larry Green)

58

February JAAD: Bridging the Specialty Gap: Update on Primary Cutaneous Lymphomas

59

March JAAD: Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: a multivariable model and web-based calculator

60

Guidelines of Care: Awareness of Comorbidities Associated with Atopic Dermatitis in Adults

61

Bonus: Vitiligo

62

Bonus: AAD 2024 Election: President-Elect Candidate Interview (Dr. Murad Alam)

63

Bonus: AAD 2024 Election: President-Elect Candidate Interview (Dr. Robert T. Brodell)

64

January JAAD: Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations/Part II: disease activity grading and therapeutic management

65

Practice Management Series: Preventing and Surviving Payer Audits

66

Practice Management Series: Coding Updates for 2024

67

November JAAD: Gaps in Medical Education Curricula on Skin of Color in Medical School, Residency, and Beyond

68

December JAAD: A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study

69

Practice Management Series: Appropriate Use of Multiple Procedure Modifiers

70

Bonus: Novel Pathways in Psoriasis - An Immunological and Pathogenic Perspective (Sponsored by Bristol Myers Squibb)

71

October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting

72

September JAAD: Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)

73

Guidelines Series: Guidelines of Care for the Management of Actinic Keratoses

74

Practice Management Series: Effective Appeals to Payer Denials

75

August JAAD: Emerging Treatments for Itch in Atopic Dermatitis: A Review

76

Bonus: Differentiating CTCL from Atopic Dermatitis and Psoriasis in Skin of Color (Sponsored by Kyowa Kirin)

77

July JAAD: Development and Multicenter International Validation of a Diagnostic Tool to Differentiate between Pemphigoid Gestationis and Polymorphic Eruption of Pregnancy

78

JAAD International Series: Q2 2023 Issue in Review

79

2023 AAD Innovation Academy Preview: Branding and the Business of Dermatology

80

June JAAD: A Comparison of Family Physician and Dermatologist Topical Corticosteroid Prescriptions: A Population-Based Cross-Sectional Study

81

Practice Management Series: Teledermatology Post PHE

82

Titans of Dermatology: Dr. June Robinson

83

May JAAD: Proteomic Characterization of Atopic Dermatitis Blood from Infancy to Adulthood

84

Leadership Series - Change Management: How to Be Flexible and Adaptable

85

Leadership Series - Leading by Negotiation and Communicating with Confidence

86

Titans of Dermatology: Dr. Jean Carruthers

87

Practice Management Series: Understanding the Difference Between Payment and Informational Modifiers

88

Practice Management Series: ADA Compliance – What You Need to Know and What’s New

89

Titans of Dermatology Series: Dr. Gary Peck

90

Bonus: Current Therapies and New Approaches in Alopecia Areata (Sponsored by Eli Lilly and Company)

91

Practice Management Series: How to Succeed in 2023 with the MIPS Program

92

Bonus: Recap of 2023 Patient Safety and Quality Symposium

93

Augmented Intelligence Series: Toward trustworthy augmented intelligence

94

Augmented Intelligence Series: Augmenting our workforce and empowering patients

95

Augmented Intelligence Series – Intro to augmented intelligence and where we are now

96

March JAAD: Sex Differences in Initial Treatment for Genital Extramammary Paget Disease in the United States: A Systematic Review

97

December JAAD: Variations in Genetics, Biology and Phenotype of Cutaneous Disorders in Skin of Color. Part I: Genetic Biological, and Structural Differences in Skin of Color

98

April JAAD: A Propensity Score Matched Cohort Study Identifying an Association of Acne, But Not Oral Antibiotic or Isotretinoin Use, With Risk of Incident Inflammatory Bowel Disease

99

Bonus: AAD 2023 Election: President-Elect (Dr. Susan Taylor) and Vice-President Elect (Dr. Kevin Cooper)

100

Bonus: Gaps in Research in Psoriasis (Sponsored by Bristol Myers Squibb)

101

Bonus: Getting to Know Your President and Vice President

102

Practice Management Series: Understanding patients’ rights to access medical records

103

JAAD International Series: Q1 2023 Issue in Review

104

February JAAD: Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study

105

Bonus: AAD 2023 Election: President-Elect Candidate Interview (Dr. Andrew Weinstein)

106

Bonus: AAD 2023 Election: President-Elect Candidate Interview (Dr. Susan Taylor)

107

Bonus: The History of Dermatology

108

Guidelines Series: Guidelines of Care for the Management and Treatment of Pediatric Psoriasis

109

Bonus: Hairstyling and Alopecia - What Dermatologists Need to Know (Sponsored by Eli Lilly and Company)

110

Bonus: Advances in the Understanding of Alopecia Areata Pathogenesis (Sponsored by Eli Lilly and Company)

111

Bonus: Categorizing Psoriasis Severity (Sponsored by Bristol Myers Squibb)

112

Bonus: Transition to Retirement and How to Sell Your Practice

113

Bonus: Actinic Keratosis (Sponsored by Almirall)

114

Guidelines Series: Psoriasis Topicals and Non-Biologic Care Improvement Strategies

115

Bonus: AAD Consumer Positioning Strategy

116

October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study

117

JAAD International Series: Q4 2022 Issue in Review

118

Practice Management Series: Financial Management for the Dermatologist

119

November JAAD: Similar response to biologic therapy across racial and ethnic groups among psoriasis patients enrolled in the CorEvitas Psoriasis Registry

120

Practice Management Series: Coding Updates for 2023 in a Nutshell

121

Bonus: 2022 Derm Tank in Review

122

Practice Management Series: Managing an Effective Team in a Busy Dermatology Clinic

123

Titans of Dermatology Series: Dr. William (Bill) James

124

Practice Management Series: Removal of Cutaneous, Epidermal, or Dermal Lesions with Histopathologic Examination

125

Practice Management Series: Step Therapy and Prior Authorization Updates

126

Bonus: Access/Health Equity with Biosimilars (Sponsored by the Biosimilars Forum)

127

September JAAD: Cutaneous manifestations of chimeric antigen receptor T cell therapy: an introduction for dermatologists

128

Bonus: Mechanism of Action Approach to Acne Treatment - Combination Therapy Targeting Root Causes (Sponsored by Almirall)

129

Bonus: Accessing the New World of Biosimilars - Implications for Patient Care and Treatment Selection (Sponsored by the Biosimilars Forum)

130

Bonus: Physician Preferences with Biosimilars (Sponsored by the Biosimilars Forum)

131

Bonus: Skin of Color Curriculum

132

Bonus: Managing Systemic Therapy for Acne Across the Spectrum of Disease (Sponsored by Almirall)

133

August JAAD: Antihistamine Safety in Older Adult Dermatologic Patients

134

July JAAD: Emerging Therapeutics in the Management of Connective Tissue Disease. Part I. Lupus Erythematosus and Sjögren’s Syndrome Date

135

Practice Management Series: Don’t Say Yes Too Soon! Key Issues in Negotiating Payer Contracts

136

Practice Management Series: Optimizing Your Office: From Practice Workflows to Improving Your EHR Practices

137

Bonus: Monkeypox in 2022 - What Dermatologists Need to Know

138

Bonus: Thriving in Chaos – Strategies to Get Control of Time and Your Life

139

Titans of Dermatology Series: Dr. Algin Garrett

140

Bonus: Dealing with Non-Responders to Systemic Therapy for Basal Cell Carcinoma (Sponsored by Genentech)

141

Bonus: MSDO Exam

142

June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations

143

Practice Management Series: Reporting Mohs Surgery with a Simple Repair

144

Bonus: Diagnosing Basal Cell Carcinoma - What's Next (Sponsored by Genentech)

145

Bonus: Recap of Patient Safety and Quality Symposium

146

Practice Management Series: Social Media in Dermatology

147

Guidelines Series: Psoriasis Phototherapy Guidelines and Care Improvement Strategies

148

Bonus: Physician Mental Health Awareness

149

May JAAD: Comorbidity screening in Hidradenitis Suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

150

Dialogues in Dermatology: JAK Inhibitors

151

Bonus: Nonsurgical Treatment of Basal Cell Carcinoma (Sponsored by Genentech)

152

Practice Management Series: Teledermatology Post COVID-19

153

Bonus: AAD 2022 Election: Vice President-Elect Interview (Dr. Cyndi Yag-Howard)

154

Bonus: AAD 2022 Election: President-Elect Interview (Dr. Seemal Desai)

155

March JAAD: Diagnosing muscle disease in a cohort of classic dermatomyositis patients see at a rheumatologic dermatology outpatient clinic

156

Practice Management Series: Top Administrative Burdens in Dermatology and How to Relieve Them

157

Practice Management Series: Coding and Reporting for Immunohistochemistry and Staining in Dermatology

158

Bonus: AAD 2022 Election: President-Elect Candidate Interview (Dr. Robert T. Brodell)

159

Bonus: AAD 2022 Election: President-Elect Candidate Interview (Dr. Seemal R. Desai)

160

Bonus: DataDerm - Synergistic Access to Data (Part II: Current Initiatives and Future Directions)

161

January JAAD: Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6-months: a prospective analysis in the Corrona Psoriasis Registry

162

February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

163

December JAAD: Clinical mimickers of calciphylaxis: A retrospective study

164

Bonus: Best of AAD 2021 Summer Meeting

165

COVID-19 Series: Cutaneous Manifestations of COVID-19 in Children

166

COVID-19 Series: COVID-19 Vaccine Boosters for Dermatology Patients

167

Bonus: DataDerm - Synergistic Access to Data (Part I: Academic Medical Center Integration and Onboarding)

168

Titans of Dermatology Series: Dr. Ken Greer

169

November JAAD: Analysis of Hidradenitis Suppurativa Hospitalizations: A Report From The National Inpatient Sample

170

October JAAD: Is Melanoma Overdiagnosed? A Review of the Evidence

171

September JAAD: Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision

172

August JAAD: Comparative Safety of Systemic Immuno-modulatory Medications in Audits with Atopic Dermatitis

173

Eating Well? The Link Between Nutrition and Your Skin’s Health: Sponsored by the Almond Board of California

174

COVID-19 Series: COVID-19 Vaccine Hesitancy

175

AAD Guidelines of Care: Managing Co-Morbidities Associated with Psoriasis

176

Practice Management Series: Prioritizing physician’s judgement in patient care; responding to non-medical switching patterns

177

Titans of Dermatology Series: Dr. Dirk Elston

178

Bonus: Best of VMX 2021

179

Bonus: AIDS 40th Anniversary: Dermatology's Impact on HIV Disease

180

Career Launch Series: Adding a Skill to Your Repertoire - Lasers & Devices

181

Career Launch Series: Adding a Skill to Your Repertoire – Cosmeceuticals

182

Clinical Practice Guideline Overview: Management of Actinic Keratosis

183

Diet & Skin Health: Sponsored by the Almond Board of California

184

Practice Management Series: Patients Right to Access Medical Records

185

June JAAD: Risk of liver disease in patients with psoriasis, psoriatic arthritis, andrheumatoid arthritis receiving methortrexate: a population-based study

186

Titans of Dermatology Series: Dr. John Zitelli

187

Practice Management Series: How the new E/M codes will impact your day to day operations

188

Kidney Disease Associated Pruritus: Sponsored by Cara Therapeutics

189

Chronic Itch: Sponsored by Cara Therapeutics

190

Titans of Dermatology Series: Dr. Mary Maloney

191

May JAAD: Clinical size is a poor predictor or invasion in melanoma of the lentigo maligna type

192

Career Launch Series: Managing Staff (Coaching vs Counseling)

193

Solving Clinical Problems through Innovation: A Conversation with The Magic Wand Initiative

194

Career Launch Series: I Got Hired, Now What?

195

AAD 2021 Election: President Elect

196

AAD 2021 Election: Vice President Elect

197

AAD Guidelines of Care: Psoriasis

198

April JAAD: Narrow resection margins are not associated with mortality or recurrence in patients with Merkel cell carcinoma: a retrospective study

199

Career Launch Series: Considerations in Contract Negotiations

200

Titans of Dermatology Series: Dr. Suephy Chen

201

AAD 2021 Election: Your Vote Matters – Young Physician Voices

202

AAD 2021 Election: Your Vote Matters – Organization Impact

203

March JAAD: Oral minoxidil treatment for hair Loss: A review of efficacy and safety

204

Practice Management Series: Best Practices in Dermatology Office Staffing

205

AAD 2021 Election: President-Elect Candidate Interview (Dr. Susan Taylor)

206

AAD 2021 Election: President-Elect Candidate Interview (Dr. Terrence Cronin, Jr.)

207

AAD Diversity, Equity, and Inclusion Plan

208

February JAAD: The dermatoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis

209

Titans of Dermatology Series: Dr. Jean Bolognia

210

January JAAD: Axial psoriatic arthritis: An update for dermatologists

211

Titans of Dermatology: Dr. Dan Siegel

212

COVID-19 Series: Mask Dermatitis

213

Practice Management Series: Pearls for Successful E/M Coding for Office Visits in 2021 and Beyond

214

JAAD Podcast: TNF- Inhibitor-Induced psoriasis: A decade of experience at the Cleveland Clinic

215

JAAD Podcast: Treatment of keloids with a single dose of low energy superficial X-ray radiation to prevent recurrence after surgical excision: an in vitro and in vivo study

216

Career Launch Series: Cash Pay (no insurance model)

217

Career Launch Series: Marketing

218

Practice Management Series: Prior Authorization: What a Pain!

219

Career Launch Series: Navigating the Changing Landscape of Medicine

220

Practice Management Series: E/M and Coding Changes for 2021

221

JAAD Podcast: Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: a US national and tertiary care center study

222

Practice Management Series: Office Optimization

223

JAAD Podcast: The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19

224

JAAD Podcast: Racial Differences in Time to Treatment for Melanoma

225

Practice Management Series: Modifier 59

226

Career Launch Series: Career Pearls From an Expert

227

JAAD Podcast: Dupilumab improves clinical manifestations, symptoms and quality of life in adult patients with chronic nodular prurigo

228

Career Launch Series: Perspectives Tangential Dermatology Careers

229

Practice Management Series: How to Improve Your Documentation to Curb Denials

230

AAD Re-Branding

231

Pain Free Dermatology - Minimizing Discomfort in Procedures for Children and Adults

232

Practice Management Series: Telederm - Hybrid Workflows

233

Career Launch Series: Perspectives on an Academic Practice

234

Career Launch Series: Perspectives on Group Practice

235

Career Launch Series: Perspectives on Solo Practice

236

JAAD Podcast: Predictors of hospital readmission in US adults with psoriasis

237

JAAD Podcast: High-dose, high frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa

238

JAAD Podcast: Comparison between organismal staining on histology and tissue culture in the diagnosis of cutaneous infection: a retrospective study

239

Practice Management Series: Medicare policy: What’s ahead in 2021?

240

Quality Podcast: Procedures and Measures

241

Guideline Series: Hidradenitis Suppurativa Guidelines (Part II)

242

Guideline Series: Hidradenitis Suppurativa Guidelines (Part I)

243

Why you should apply for the Assistant Secretary-Treasurer position

244

COVID-19 Series: UV Germicidal Irradiation as Possible Method for Respirator Disinfection during COVID-19 Pandemic

245

COVID-19 Series: Skin Signs of Covid-19 Infection

246

Practice Management Series: Challenges in ICR Coding

247

Interview with AAD President-Elect

248

COVID-19 Series: COVID-19 Dermatology Roundtable

249

COVID-19 Series: What Are We Doing in the Dermatology Outpatient Department?

250

COVID-19 Series: Navigating Practice During COVID-19 – AAD Resources and Embracing Teledermatology

251

JAAD Podcast: Janus Kinase Inhibition

252

Career Launch Series - Social Media

253

Career Launch Series - Reputation Management

254

Career Launch Series - A Success Story

255

JAAD Podcast: Evaluating Patients Unmet Needs in Hidradentitis Suppurativa

256

Bonus - February 2020

257

JAAD Podcast: Clinical Utility of Laboratory Monitoring During Isotretinoin Therapy for Acne and Changes to Monitoring Practices Over Time

258

Bonus - January 2020

259

JAAD Podcast: Examining the prior authorization process

260

Bonus 2 - December 2019

261

Career Launch Series - Work Life Balance

262

Bonus - October 2019

263

JAAD Podcast: Acute inflammatory Edema

264

JAAD Podcast: The Etiology, Diagnosis and Management of Hyperhidrosis: A Comprehensive Review

265

Bonus - September 2019